Moxetumomab pasudotox-tdfk Intravenous and Promethazine VC
Determining the interaction of Moxetumomab pasudotox-tdfk Intravenous and Promethazine VC and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: phenylephrine / promethazine
Brand name: Promethazine VC, Phenergan VC, Promethazine VC Plain
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-tdfk Intravenous-Promethazine VC Plain
- Moxetumomab pasudotox-tdfk Intravenous-Promethazine VC with Codeine
- Moxetumomab pasudotox-tdfk Intravenous-Promethazine with Codeine
- Moxetumomab pasudotox-tdfk Intravenous-Promethazine with Dextromethorphan
- Moxetumomab pasudotox-tdfk Intravenous-Promethazine with DM
- Moxetumomab pasudotox-tdfk Intravenous-Promethazine, Phenylephrine, and Codeine
- Promethazine VC-Moxifloxacin
- Promethazine VC-Moxifloxacin (Systemic)
- Promethazine VC-Moxifloxacin Hydrochloride
- Promethazine VC-Moxifloxacin Injection
- Promethazine VC-Moxifloxacin Intravenous
- Promethazine VC-Moxifloxacin Tablets